GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » Ending Cash Position

Sinocelltech Group (SHSE:688520) Ending Cash Position : ¥340 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group Ending Cash Position?

Sinocelltech Group's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥340 Mil.

Sinocelltech Group's quarterly Ending Cash Position declined from Sep. 2023 (¥409 Mil) to Dec. 2023 (¥293 Mil) but then increased from Dec. 2023 (¥293 Mil) to Mar. 2024 (¥340 Mil).

Sinocelltech Group's annual Ending Cash Position increased from Dec. 2021 (¥349 Mil) to Dec. 2022 (¥971 Mil) but then declined from Dec. 2022 (¥971 Mil) to Dec. 2023 (¥293 Mil).


Sinocelltech Group Ending Cash Position Historical Data

The historical data trend for Sinocelltech Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group Ending Cash Position Chart

Sinocelltech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 163.80 950.28 349.49 971.06 293.37

Sinocelltech Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 545.33 550.19 409.08 293.37 339.78

Sinocelltech Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sinocelltech Group's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=971.058+-677.687
=293

Sinocelltech Group's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=293.371+46.405
=340


Sinocelltech Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocelltech Group (SHSE:688520) Business Description

Traded in Other Exchanges
N/A
Address
Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.
Executives
Xie Liang Zhi Director

Sinocelltech Group (SHSE:688520) Headlines

No Headlines